# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-006905
Filing Date
2023-03-16
Accepted
2023-03-16 16:23:43
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | zvra20230315_defa14a.htm | DEFA14A | 15140
2 |  | page1.jpg | GRAPHIC | 338878
3 |  | page2.jpg | GRAPHIC | 375149
4 |  | page3.jpg | GRAPHIC | 359365
5 |  | page4.jpg | GRAPHIC | 424166
| Complete submission text file | 0001437749-23-006905.txt |  | 2079092

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36913 | Film No.: 23739143
SIC: 2834 Pharmaceutical Preparations